Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion
- PMID: 7542167
Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion
Abstract
Galectin-3 (Gal-3) is a beta-galactoside-binding protein with M(r) approximately 30,000. Cell surface Gal-3 is postulated to be involved in homotypic aggregation of tumor cells in the circulation during metastasis through attachment to a complementary serum glycoprotein(s), which serves as a cross-linking bridge between adjacent cells. To test this hypothesis a recombinant strain of baculovirus encoding Gal-3 was used to infect Sf9 insect cells, which lack endogenous Gal-3. Immunoblotting and indirect immunofluorescence studies revealed that the infection with recombinant virus conferred Gal-3 expression on Sf9 cells, and the Gal-3 was localized on the cell surface as well as in the cytoplasm. Sf9 cells infected with recombinant virus underwent homotypic aggregation in the presence of exogenous glycoprotein (i.e., asialofetuin), whereas control cells uninfected or infected with wild-type virus did not. Lactose and Fab' fragments of anti-Gal-3 antibodies markedly inhibited the cell-cell aggregation. Moreover, cosuspension of Sf9 cells infected with the recombinant virus with uninfected cells in the presence of asialofetuin resulted in a preferential cell-cell adhesion of the Gal-3-expressing cells. These results directly demonstrate the ability of cell surface Gal-3 molecules to mediate homotypic cell adhesion by bridging through branched, soluble complementary glycoconjugates.
Similar articles
-
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.Cancer Res. 1996 Oct 1;56(19):4530-4. Cancer Res. 1996. PMID: 8813152
-
Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.Exp Cell Res. 1997 Sep 15;235(2):374-84. doi: 10.1006/excr.1997.3685. Exp Cell Res. 1997. PMID: 9299162
-
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.Cancer Res. 2003 Dec 1;63(23):8302-11. Cancer Res. 2003. PMID: 14678989
-
Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin.Cancer Res. 2001 Mar 1;61(5):1869-73. Cancer Res. 2001. PMID: 11280740
-
Endogenous lectins as mediators of tumor cell adhesion.J Cell Biochem. 1988 May;37(1):107-17. doi: 10.1002/jcb.240370110. J Cell Biochem. 1988. PMID: 3292544 Review.
Cited by
-
Galectin-3-independent Down-regulation of GABABR1 due to Treatment with Korean Herbal Extract HAD-B Reduces Proliferation of Human Colon Cancer Cells.J Pharmacopuncture. 2012 Sep;15(3):19-30. doi: 10.3831/KPI.2012.15.002. J Pharmacopuncture. 2012. PMID: 25780644 Free PMC article.
-
Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.J Clin Invest. 1997 May 15;99(10):2452-61. doi: 10.1172/JCI119429. J Clin Invest. 1997. PMID: 9153289 Free PMC article.
-
Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3.Glycoconj J. 2009 May;26(4):445-56. doi: 10.1007/s10719-008-9194-9. Epub 2008 Oct 24. Glycoconj J. 2009. PMID: 18949555
-
Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells.Oncotarget. 2017 Sep 21;8(60):101475-101488. doi: 10.18632/oncotarget.21135. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254179 Free PMC article.
-
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics.Acta Histochem. 2011 May;113(3):236-47. doi: 10.1016/j.acthis.2010.02.004. Epub 2010 Mar 2. Acta Histochem. 2011. PMID: 20199800 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials